Sourav Banerjee

1.5k total citations
33 papers, 973 citations indexed

About

Sourav Banerjee is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Sourav Banerjee has authored 33 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Organic Chemistry and 8 papers in Cell Biology. Recurrent topics in Sourav Banerjee's work include Synthesis and biological activity (9 papers), Ubiquitin and proteasome pathways (9 papers) and Multicomponent Synthesis of Heterocycles (6 papers). Sourav Banerjee is often cited by papers focused on Synthesis and biological activity (9 papers), Ubiquitin and proteasome pathways (9 papers) and Multicomponent Synthesis of Heterocycles (6 papers). Sourav Banerjee collaborates with scholars based in United Kingdom, United States and India. Sourav Banerjee's co-authors include Jack E. Dixon, Xing Guo, Joshua E. Mayfield, Alan R. Prescott, Dario R. Alessi, Mária Deák, Anna Zagórska, Laureano de la Vega, Junyu Xiao and Jing Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Cell Biology.

In The Last Decade

Sourav Banerjee

30 papers receiving 960 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sourav Banerjee United Kingdom 16 653 180 177 136 105 33 973
Paige Yellen United States 10 589 0.9× 166 0.9× 117 0.7× 47 0.3× 137 1.3× 10 888
Yumiko Hirokawa Australia 19 528 0.8× 271 1.5× 106 0.6× 90 0.7× 61 0.6× 31 910
Benny Zhitomirsky Israel 7 491 0.8× 200 1.1× 97 0.5× 44 0.3× 111 1.1× 7 860
Mei Shan Ong Singapore 8 542 0.8× 131 0.7× 105 0.6× 29 0.2× 197 1.9× 12 911
Hanshuo Yang China 22 656 1.0× 261 1.4× 195 1.1× 49 0.4× 228 2.2× 57 1.2k
Rocco Palermo Italy 24 849 1.3× 237 1.3× 72 0.4× 49 0.4× 234 2.2× 38 1.2k
Alice Hlobílková Czechia 15 576 0.9× 252 1.4× 87 0.5× 55 0.4× 170 1.6× 26 889
Kaiji Hu Canada 23 1.1k 1.6× 468 2.6× 148 0.8× 74 0.5× 284 2.7× 30 1.7k
Wen Zhou China 22 1.2k 1.8× 427 2.4× 80 0.5× 56 0.4× 316 3.0× 48 1.6k

Countries citing papers authored by Sourav Banerjee

Since Specialization
Citations

This map shows the geographic impact of Sourav Banerjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sourav Banerjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sourav Banerjee more than expected).

Fields of papers citing papers by Sourav Banerjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sourav Banerjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sourav Banerjee. The network helps show where Sourav Banerjee may publish in the future.

Co-authorship network of co-authors of Sourav Banerjee

This figure shows the co-authorship network connecting the top 25 collaborators of Sourav Banerjee. A scholar is included among the top collaborators of Sourav Banerjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sourav Banerjee. Sourav Banerjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nogales, Joaquina, et al.. (2025). Ethanol-mediated one-pot synthesis of 3-phenyl-3,4,5,12-tetrahydrobenzo[4,5]imidazo[2,1-b]quinazolin-1(2H)-ones as PDGFRA inhibitors. European Journal of Medicinal Chemistry. 297. 117914–117914.
3.
Kashyap, S.K., et al.. (2025). QSAR, Antimicrobial, and Antiproliferative Study of (R/S)-2-Thioxo-3,4-dihydropyrimidine-5-carboxanilides. ACS Omega. 10(7). 7013–7026. 2 indexed citations
5.
Nogales, Joaquina, et al.. (2024). Alkoxy-functionalised dihydropyrimido[4,5-b]quinolinones enabling anti-proliferative and anti-invasive agents. Chemical Communications. 60(55). 7093–7096. 8 indexed citations
6.
Joseph, James, et al.. (2024). The abscopal effects of sonodynamic therapy in cancer. British Journal of Cancer. 132(5). 409–420. 17 indexed citations
8.
Nogales, Joaquina, Amit Kumar, Dhanji P. Rajani, et al.. (2024). Indole clubbed 2,4‐thiazolidinedione linked 1,2,3‐triazole as a potent antimalarial and antibacterial agent against drug‐resistant strain and molecular modeling studies. Archiv der Pharmazie. 357(4). e2300673–e2300673. 25 indexed citations
10.
Baxter, Mark, et al.. (2023). Sacral ependymoma presents 20 years after initial posterior fossa lesion. BMJ Case Reports. 16(10). e256611–e256611. 2 indexed citations
11.
Moreno, Rita, Kira Allmeroth, Jean A. Quinn, et al.. (2023). Dual inhibition of HSF1 and DYRK2 impedes cancer progression. Bioscience Reports. 43(1). 10 indexed citations
12.
Thakur, Abhimanyu, Lifan Liang, Sourav Banerjee, & Kui Zhang. (2023). Single-Cell Transcriptomics Reveals Evidence of Endothelial Dysfunction in the Brains of COVID-19 Patients with Implications for Glioblastoma Progression. Brain Sciences. 13(5). 762–762. 8 indexed citations
13.
Vala, Ruturajsinh M., Albert Chen, Robert L. Sah, et al.. (2022). Syrbactin-class dual constitutive- and immuno-proteasome inhibitor TIR-199 impedes myeloma-mediated bone degeneration in vivo. Bioscience Reports. 42(2). 16 indexed citations
14.
Vala, Ruturajsinh M., et al.. (2022). Synthesis of N -(4-chlorophenyl) substituted pyrano[2,3-c]pyrazoles enabling PKBβ/AKT2 inhibitory and in vitro anti-glioma activity. Annals of Medicine. 54(1). 2548–2560. 23 indexed citations
15.
Worby, Carolyn A., et al.. (2021). The ABCs of the atypical Fam20 secretory pathway kinases. Journal of Biological Chemistry. 296. 100267–100267. 30 indexed citations
16.
Vega, Laureano de la, et al.. (2020). Emerging roles of DYRK2 in cancer. Journal of Biological Chemistry. 296. 100233–100233. 43 indexed citations
17.
Banerjee, Sourav, Tiantian Wei, Jue Wang, et al.. (2019). Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression. Proceedings of the National Academy of Sciences. 116(49). 24881–24891. 46 indexed citations
18.
Qiu, Yimin, Erik Poppleton, Hongtao Yu, et al.. (2018). Enzymatic Phosphorylation of Ser in a Type I Collagen Peptide. Biophysical Journal. 115(12). 2327–2335. 14 indexed citations
19.
Todoric, Jelena, Laura Antonucci, Giuseppe Di, et al.. (2017). Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas. Cancer Cell. 32(6). 824–839.e8. 109 indexed citations
20.
Cozza, Giorgio, Mauro Salvi, Sourav Banerjee, et al.. (2015). A new role for sphingosine: Up-regulation of Fam20C, the genuine casein kinase that phosphorylates secreted proteins. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1854(10). 1718–1726. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026